Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

Organon

Status and phase

Completed

Phase 4

Conditions

Chronic Low Back Pain

Treatments

Drug: Comparator: diclofenac / Duration of Treatment: 4 weeks

Drug: MK0663, etoricoxib / Duration of Treatment: 4 weeks

Study type

Interventional

Funder types

Industry

Identifiers

NCT00090181

0663-806

2004_003

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.

Enrollment

401 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition.
Patients should have at least 3 months of Low Back Pain.